Avastin+P-Gemox方案治疗NK/T细胞淋巴瘤患者不良反应的护理被引量：1

导出

摘要总结了16例经Avastin+P-Gemox方案治疗NK/T细胞淋巴瘤患者不良反应的护理要点。具体内容包括用药方法、心理护理、化疗不良反应的观察及护理。认为通过优质的护理可减少化疗药物毒剂反生的发生率,降低患者的痛苦,从而使患者树立信心,达到最佳治疗效果。

作者彭丽娟杨艳利

机构地区中山大学肿瘤防治中心

出处《当代护士（中旬刊）》 2019年第5期92-93,共2页 Modern Nurse

关键词 Avastin+P-Gemox NK/T细胞淋巴瘤不良反应护理

分类号 R473.73 [医药卫生—护理学]

引文网络
相关文献

参考文献4

1王潇潇,黄慧强.结外NK/T细胞淋巴瘤治疗新进展[J].实用医院临床杂志,2011,8(4):24-27. 被引量：6
2邓于宏,孔珍其,石洋.培门冬酶联合Chop方案治疗NK/T细胞淋巴瘤病人不良反应的护理[J].全科护理,2016,14(3):297-298. 被引量：2
3付艳枝,戴德兰,冀小平,张海霞,张琼.奥沙利铂方案化疗治疗晚期结直肠癌毒副反应的观察和护理[J].海南医学,2009,20(1):126-128. 被引量：8
4方英立,王秀问.奥沙利铂致阿-斯综合征1例[J].中国新药与临床杂志,2009,28(4):317-318. 被引量：4

二级参考文献38

1潘战和,黄慧强,林旭滨,夏云飞,夏忠军,彭玉龙,蔡清清,林桐榆,姜文奇,管忠震.鼻型NK/T细胞非霍奇金淋巴瘤预后因素探讨(附93例长期随访结果分析)[J].癌症,2005,24(12):1493-1497. 被引量：24
2Levi F,Misset JL,Brienza S,et al. A chronopharmacologic phase Ⅱ clinical trial with 5 -fluorouracil ,folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Highantitumor ef- fectiveness against metastatic colorectal cancer[ J]. Cancer, 1992 , 69(4): 893 -900.
3Woynarowski J, Faivres S, Herzig M, et al. Oxaliplatin - induced damage of cellular DNA [J]. Mol Pharmacol,2000 ,58(5 ) : 920 - 927.
4THOMAS RR, QUINN MG, SCHULER B, et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin[J]. Cancer, 2003, 97 (9) : 2301-2307.
5张锡芹,郭其森,步兵,吴宁,刘志芳,王明玉.奥沙利铂致过敏反应12例临床分析[J].中华肿瘤防治杂志,2007,14(16):1279-1279. 被引量：19
6Kim BS,Kim TY,Kim CW,et al.Therapeutic outcomeof extranodal NK/T cell lymphoma initially treated with chemotherapy result of chemotherapyin NK/T cell Lymphoma[J].Acta Oncol,2003,42:779.
7Kim GE,Lee SW,Chang SK,et al.Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck[J].Radiother Oncol,2001,61:261.
8Li YX,Yao B,Jin J,et al.Radiotherapyasprimarytreatmentfor stage IE and IIE Nasal natural killer/T cell Lymphoma[J].J Clin Oncol,2006,20:181.
9Kim SJ,Kim K,Kim BS,et al.Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed,stage IE to IIE,nasal,extranodal NK/T-cell lymphoma:consortium for improving survival of lymphoma study[J].J Clin Oncol,2009,27(35):6027-6032.
10Weiben Y,Wen Z,Jun Z,et al.MidlineNK/T cell lymphoma nasal type:treatment outcome,the effect of L-asparaginase based regimen,and prognostic factors[J].Hematol Oncol,2006,24:28.